Global Teduglutide
Market Report
2025
Delivery Includes:- Market Timeline 2021 till 2033, Market Size, Revenue/Volume Share, Forecast and CAGR, Competitor Analysis, Regional Analysis, Country Analysis, Segment Analysis, Market Trends, Drivers, Opportunities, Restraints, ESG Analysis, Porters Analysis, PESTEL Analysis, Market Attractiveness, Patent Analysis, Technological Trend, SWOT Analysis, COVID-19 Analysis, Consumer Behavior Analysis, etc.
The base year for the calculation is 2024. The historical will be 2021 to 2024. The year 2025 will be estimated one while the forecasted data will be from year 2025 to 2033. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
Share your contact details to receive free updated sample copy/pages of the recently published edition of Teduglutide Market Report 2025.
"Global Teduglutide market size 2025 is $870.4 Million whereas according out published study it will reach to $2853.53 Million by 2033. Teduglutide market will be growing at a CAGR of 16% during 2025 to 2033."
As per the current market study, out of 870.4 Million USD global market revenue 2025, North America market holds 29.00% of the market share. The North America Teduglutide industry grew from 140.369 Million USD in 2021 to 252.416 Million USD in 2025 and will record 55.61% growth. In coming future this industry will reach 818.964 Million by 2033 with a 15.849% CAGR. If we look at the percentage market shares of top North America countries for 2025,Mexico (3.20%), Canada (12.50%), United States (84.30%)
As per the current market study, out of 870.4 Million USD global market revenue 2025, Europe market holds 27.00% of the market share. The Europe Teduglutide industry grew from 130.754 Million USD in 2021 to 235.008 Million USD in 2025 and will record 55.64% growth. In coming future this industry will reach 750.479 Million by 2033 with a 15.62% CAGR. If we look at the percentage market shares of top Europe countries for 2025,Luxembourg (1.90%), Germany (20.00%), Switzerland (2.60%), Spain (7.30%), United Kingdom (14.60%), Denmark (2.40%), Russia (11.10%), Sweden (3.00%), Italy (7.20%), France (11.50%), Rest of Europe (18.40%)
As per the current market study, out of 870.4 Million USD global market revenue 2025, Asia Pacific market holds 33.00% of the market share. The Asia Pacific Teduglutide industry grew from 157.674 Million USD in 2021 to 287.232 Million USD in 2025 and will record 54.89% growth. In coming future this industry will reach 950.226 Million by 2033 with a 16.131% CAGR. If we look at the percentage market shares of top Asia Pacific countries for 2025,South East Asia (7.00%), China (43.10%), Australia (2.70%), South Korea (6.00%), India (17.50%), Singapore (1.30%), Japan (11.00%), Rest of APAC (11.40%)
2024 | 2025 | 2032 | 2033 | CAGR | |
---|---|---|---|---|---|
Global Teduglutide Market Sales Revenue | 121212 | $ 870.4 Million | 121212 | $ 2853.53 Million | 16% |
North America Teduglutide Market Sales Revenue | 121212 | $ 252.416 Million | 121212 | $ 818.964 Million | 15.849% |
Mexico Teduglutide Market Sales Revenue | 121212 | $ 8.077 Million | 121212 | $ 30.302 Million | 17.971% |
Canada Teduglutide Market Sales Revenue | 121212 | $ 31.552 Million | 121212 | $ 99.095 Million | 15.379% |
United States Teduglutide Market Sales Revenue | 121212 | $ 212.787 Million | 121212 | $ 689.567 Million | 15.832% |
Europe Teduglutide Market Sales Revenue | 121212 | $ 235.008 Million | 121212 | $ 750.479 Million | 15.62% |
Luxembourg Teduglutide Market Sales Revenue | 121212 | $ 4.465 Million | 121212 | $ 13.509 Million | 14.841% |
Germany Teduglutide Market Sales Revenue | 121212 | $ 47.002 Million | 121212 | $ 148.595 Million | 15.475% |
Switzerland Teduglutide Market Sales Revenue | 121212 | $ 6.11 Million | 121212 | $ 18.011 Million | 14.469% |
Spain Teduglutide Market Sales Revenue | 121212 | $ 17.156 Million | 121212 | $ 54.034 Million | 15.421% |
United Kingdom Teduglutide Market Sales Revenue | 121212 | $ 34.311 Million | 121212 | $ 108.069 Million | 15.421% |
Denmark Teduglutide Market Sales Revenue | 121212 | $ 5.64 Million | 121212 | $ 17.261 Million | 15.006% |
Russia Teduglutide Market Sales Revenue | 121212 | $ 26.086 Million | 121212 | $ 81.052 Million | 15.224% |
Sweden Teduglutide Market Sales Revenue | 121212 | $ 7.05 Million | 121212 | $ 19.512 Million | 13.57% |
Italy Teduglutide Market Sales Revenue | 121212 | $ 16.921 Million | 121212 | $ 53.284 Million | 15.418% |
France Teduglutide Market Sales Revenue | 121212 | $ 27.026 Million | 121212 | $ 85.555 Million | 15.494% |
Rest of Europe Teduglutide Market Sales Revenue | 121212 | $ 43.241 Million | 121212 | $ 151.597 Million | 16.977% |
Asia Pacific Teduglutide Market Sales Revenue | 121212 | $ 287.232 Million | 121212 | $ 950.226 Million | 16.131% |
South East Asia Teduglutide Market Sales Revenue | 121212 | $ 20.106 Million | 121212 | $ 63.665 Million | 15.497% |
China Teduglutide Market Sales Revenue | 121212 | $ 123.797 Million | 121212 | $ 412.398 Million | 16.232% |
Australia Teduglutide Market Sales Revenue | 121212 | $ 7.755 Million | 121212 | $ 22.805 Million | 14.434% |
South Korea Teduglutide Market Sales Revenue | 121212 | $ 17.234 Million | 121212 | $ 56.063 Million | 15.888% |
India Teduglutide Market Sales Revenue | 121212 | $ 50.266 Million | 121212 | $ 169.14 Million | 16.378% |
Singapore Teduglutide Market Sales Revenue | 121212 | $ 3.734 Million | 121212 | $ 9.502 Million | 12.384% |
Japan Teduglutide Market Sales Revenue | 121212 | $ 31.596 Million | 121212 | $ 103.575 Million | 15.999% |
Rest of APAC Teduglutide Market Sales Revenue | 121212 | $ 32.744 Million | 121212 | $ 113.077 Million | 16.756% |
South America Teduglutide Market Sales Revenue | 121212 | $ 20.671 Million | 121212 | $ 34.816 Million | 102.727% |
Colombia Teduglutide Market Sales Revenue | 121212 | $ 3.69 Million | 121212 | $ 10.684 Million | 14.21% |
Argentina Teduglutide Market Sales Revenue | 121212 | $ 5.64 Million | 121212 | $ 16.334 Million | 14.215% |
Brazil Teduglutide Market Sales Revenue | 121212 | $ 15.702 Million | 121212 | $ 46.638 Million | 14.577% |
Chile Teduglutide Market Sales Revenue | 121212 | $ 2.611 Million | 121212 | $ 7.602 Million | 14.29% |
Peru Teduglutide Market Sales Revenue | 121212 | $ 2.785 Million | 121212 | $ 7.91 Million | 13.937% |
Rest of South America Teduglutide Market Sales Revenue | 121212 | $ 4.387 Million | 121212 | $ 13.56 Million | 15.15% |
Middle East Teduglutide Market Sales Revenue | 121212 | $ 20.19 Million | 121212 | $ 39.168 Million | 136.97% |
Turkey Teduglutide Market Sales Revenue | 121212 | $ 8.382 Million | 121212 | $ 29.175 Million | 16.871% |
Qatar Teduglutide Market Sales Revenue | 121212 | $ 2.428 Million | 121212 | $ 8.355 Million | 16.702% |
Egypt Teduglutide Market Sales Revenue | 121212 | $ 5.914 Million | 121212 | $ 20.545 Million | 16.843% |
UAE Teduglutide Market Sales Revenue | 121212 | $ 9.635 Million | 121212 | $ 34.242 Million | 17.176% |
Saudi Arabia Teduglutide Market Sales Revenue | 121212 | $ 7.285 Million | 121212 | $ 25.887 Million | 17.174% |
Rest of MEA Teduglutide Market Sales Revenue | 121212 | $ 5.523 Million | 121212 | $ 18.765 Million | 16.52% |
Africa Teduglutide Market Sales Revenue | 121212 | $ 11.056 Million | 121212 | $ 21.76 Million | 94.167% |
Nigeria Teduglutide Market Sales Revenue | 121212 | $ 4.657 Million | 121212 | $ 20.434 Million | 20.305% |
South Africa Teduglutide Market Sales Revenue | 121212 | $ 8.726 Million | 121212 | $ 37.572 Million | 20.021% |
Rest of Africa Teduglutide Market Sales Revenue | 121212 | $ 15.08 Million | 121212 | $ 52.596 Million | 16.902% |
Base Year | 2024 |
Historical Data Time Period | 2021-2024 |
Forecast Period | 2025-2033 |
Market Split by Type |
|
Market Split by Application |
|
List of Competitors |
|
Regional Analysis |
|
Country Analysis |
|
Market Drivers:
| |
Market Restrains:
| |
Market Trends:
|
Report scope is customizable as we have a huge database of Teduglutide industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Teduglutide Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Increasing Short Bowel Syndrome (SBS) Prevalence:
The need for teduglutide is being driven by an increase in cases brought on by congenital conditions, Crohn's disease, and surgical bowel resections.
FDA, EMA, and PMDA Approvals:
Its global reach has been enlarged by regulatory approvals in North America, Europe, and Japan.
Decrease in Reliance on Parenteral Nutrition (PN):
Teduglutide treatment considerably reduces the need for intravenous nutrition, which enhances the quality of life for patients.
High Therapy Cost:
In certain areas, the high cost of teduglutide restricts affordability and reimbursement coverage.
Small Patient Population:
Because SBS is an uncommon condition, teduglutide's total commercial potential is limited.
Side effects and safety concerns:
Issues that affect long-term adoption include cancer risk, gastrointestinal problems, and fluid overload.
Extension of Teduglutide Indications:
Research is still being conducted to assess the drug's potential for intestinal failure and gut rehabilitation following surgery.
Increase in Home-Based Administration:
Subcutaneous formulations are making it easier for patients to comply to their treatment plans.
Emerging Competition from New GLP-2 Agonists:
New treatments that promote intestinal development are being created as rivals.
Growing Funds for the Treatment of Rare Diseases:
Pharma firms are growing their pipelines for orphan drugs, which could result in a larger market.
We have various report editions of Teduglutide Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
The pharmaceutical and healthcare industry is highly competitive, with key players expanding their portfolios through new product launches, mergers and acquisitions, strategic partnerships, and regulatory approvals.
Financial performance metrics include revenue, gross margin, and market share, as well as SWOT analysis for key players. The report also evaluates companies' responses to COVID-19 challenges, including supply chain adjustments and investments in digital healthcare solutions.
The market size is projected based on global, regional, and country-level demand patterns, with research including value chain analysis, patent analysis, and competitive matrix. This comprehensive study serves as a vital resource for investors, industry stakeholders, and businesses navigating the evolving pharmaceutical and healthcare landscape.
Top Companies Market Share in Teduglutide Industry: (In no particular order of Rank)
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
Region and country analysis section of Teduglutide Industry Analysis has been segmented into 5 major region such as North America, Europe, Asia Pacific, Middle East & Africa ,and Latin America (along with respective major contributing countries) and provides the revenue share, current trends.
The base years considered for all the estimations by analyzing trends and growth rate will help you gain an in-depth understanding of the conclusions provided in this report. This report also includes figures, graphs, pie charts, tables and bar graphs that explain the data analysis based on current trends at the country level as well as key regions. This research report also focuses on assessing factors such as profit, product price, capacity, production, supply demand market growth rate along with others to create a clear picture on the future prospects of Teduglutide market.
The current report Scope analyzes Teduglutide Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
Global Teduglutide Market Report 2025 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Teduglutide Industry growth. Teduglutide market has been segmented with the help of its Type, Application , and others. Teduglutide market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
This report categorizes competitors in the pharmaceutical and healthcare market based on their product offerings and business models. It includes key details such as definitions, benefits, applications, technological advancements, and regional advantages for each type of pharmaceutical product, including small molecule drugs, biologics, and biosimilars.
Market growth figures, such as market share percentages, revenue, and growth rates (e.g., CAGR), are provided for each segment over the specified period (2019-2023). The report covers various segments
Type of Teduglutide analyzed in this report are as follows:
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Teduglutide Industry. Request a Free Sample PDF!
This report analyzes revenue growth in the pharma and healthcare industry at global, regional, and national levels, highlighting trends and opportunities for each application. It explores how sectors like pharmaceuticals, therapy, and healthcare monitoring use innovations to address healthcare needs. Key factors include market size, revenue contributions, technological advancements (e.g., AI-driven diagnostics), and regulatory considerations. The report also covers the value chain, identifying key players and processes within the industry. For more information, please request a sample or contact our research team.
Some of the key Application of Teduglutide are:
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
Senior Research Associate at Cognitive Market Research
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over three years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies.
In her current role, Manjiri handles the market research related to Pharma and healthcare industry. Her passion lies in utilizing innovative approaches to distill complex information into strategic insights that empower organizations to make informed decisions.Manjiri remains an invaluable asset in the dynamic landscape of market research.
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Teduglutide Market is witnessing significant growth in the near future.
In 2023, the Gattex segment accounted for noticeable share of global Teduglutide Market and is projected to experience significant growth in the near future.
The Hospital segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies Takeda Pharmaceuticals, and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Disclaimer:
Type | Gattex, Revestive |
Application | Hospital, Pharmacy, Other |
List of Competitors | Takeda Pharmaceuticals |
This chapter will help you gain GLOBAL Market Analysis of Teduglutide. Further deep in this chapter, you will be able to review Global Teduglutide Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
This chapter will help you gain North America Market Analysis of Teduglutide. Further deep in this chapter, you will be able to review North America Teduglutide Market Split by various segments and Country Split.
Chapter 2 North America Market Analysis
This chapter will help you gain Europe Market Analysis of Teduglutide. Further deep in this chapter, you will be able to review Europe Teduglutide Market Split by various segments and Country Split.
Chapter 3 Europe Market Analysis
This chapter will help you gain Asia Pacific Market Analysis of Teduglutide. Further deep in this chapter, you will be able to review Asia Pacific Teduglutide Market Split by various segments and Country Split.
Chapter 4 Asia Pacific Market Analysis
This chapter will help you gain South America Market Analysis of Teduglutide. Further deep in this chapter, you will be able to review South America Teduglutide Market Split by various segments and Country Split.
Chapter 5 South America Market Analysis
This chapter will help you gain Middle East Market Analysis of Teduglutide. Further deep in this chapter, you will be able to review Middle East Teduglutide Market Split by various segments and Country Split.
Chapter 6 Middle East Market Analysis
This chapter will help you gain Middle East Market Analysis of Teduglutide. Further deep in this chapter, you will be able to review Middle East Teduglutide Market Split by various segments and Country Split.
Chapter 7 Africa Market Analysis
This chapter provides an in-depth analysis of the market share among key competitors of Teduglutide. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 9 Qualitative Analysis (Subject to Data Availability)
Segmentation Type Analysis 2019 -2031, will provide market size split by Type. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Type Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by Application Analysis 2021 - 2033
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Teduglutide market
Chapter 12 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Chapter 13 Research Methodology and Sources
Why Gattex have a significant impact on Teduglutide market? |
What are the key factors affecting the Gattex and Revestive of Teduglutide Market? |
What is the CAGR/Growth Rate of Hospital during the forecast period? |
By type, which segment accounted for largest share of the global Teduglutide Market? |
Which region is expected to dominate the global Teduglutide Market within the forecast period? |
Segmentation Level Customization |
|
Global level Data Customization |
|
Region level Data Customization |
|
Country level Data Customization |
|
Company Level |
|
Additional Data Analysis |
|
Additional Qualitative Data |
|
Additional Quantitative Data |
|
Service Level Customization |
|
Report Format Alteration |
|